PK Bio :: About Us

Dr. Anumantha G Kanthasamy

President and CEO

Dr. Kanthasamy is a Distinguished Professor and the Eugene and Linda Lloyd Endowed Chair of Neurotoxicology in the Department of Biomedical Sciences at the College of Veterinary Medicine, Iowa State University.

Dr. Vellareddy Anantharam

Vice President and COO

Dr. Anantharam has over 20 years of research experience in molecular neurobiology, pharmacology and toxicology in both the academic and corporate sectors. He has more than 75 published research papers to his credit.

Newly formed scientific and business advisory groups will also assist PK Biosciences by reviewing and advising on primary development decisions as the company moves forward. These groups consist of following experts who have already accepted or agreed in principle to serve on these teams.

PK Biosciences Corporation (PK Bio) is a startup biotechnology company located in Ames, IA USA.

PK Bio is working towards developing innovative oral medicines targeting to improve the health of patients with neurodegenerative diseases.

PK Bios’ innovative medicines are targeted against selective cell death signaling molecules, which are involved in the cell survival and apoptotic cell death observed in many neurodegenerative disorders including Amyotrophic lateral sclerosis, Parkinson’s, Alzheimer’s and Huntington diseases.

PK Bios’ small molecule therapeutics candidates provide a novel neuroprotective and anti-neuroinflammatory approach designed to maximize clinical outcome and limit off-target effects.

PKBio is a private held company with corporate values. We strive for excellence, high level of productivity, conduct with integrity & high ethical standards. We respect the functional expertise and role of our colleagues. We value diversity in culture, experiences and work style.

As a development-stage company PK Biosciences Corporation value its success on partnership, collaboration and equity investment from pharmaceutical industries and venture capital investment.

We are continually looking for business partners/collaborators/ investors who can see the true long-term value of investment in this company.